Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

An in-depth analysis shows a hidden atherogenic lipoprotein profile in non-diabetic chronic kidney disease patients.

Bermudez-Lopez M, Forne C, Amigo N, Bozic M, Arroyo D, Bretones T, Alonso N, Cambray S, Del Pino MD, Mauricio D, Gorriz JL, Fernandez E, Valdivielso JM.

Expert Opin Ther Targets. 2019 Jul;23(7):619-630. doi: 10.1080/14728222.2019.1620206. Epub 2019 May 23.

PMID:
31100024
2.

The rs1126616 Single Nucleotide Polymorphism of the Osteopontin Gene Is Independently Associated with Cardiovascular Events in a Chronic Kidney Disease Cohort.

Cambray S, Galimudi RK, Bozic M, Bermúdez-López M, Rodríguez I, Valdivielso JM.

J Clin Med. 2019 Apr 29;8(5). pii: E592. doi: 10.3390/jcm8050592.

3.

Cytoplasmic cyclin D1 regulates glioblastoma dissemination.

Cemeli T, Guasch-Vallés M, Nàger M, Felip I, Cambray S, Santacana M, Gatius S, Pedraza N, Dolcet X, Ferrezuelo F, Schuhmacher AJ, Herreros J, Garí E.

J Pathol. 2019 Aug;248(4):501-513. doi: 10.1002/path.5277. Epub 2019 May 16.

PMID:
30957234
4.

Association of Candidate Gene Polymorphisms With Chronic Kidney Disease: Results of a Case-Control Analysis in the Nefrona Cohort.

Valls J, Cambray S, Pérez-Guallar C, Bozic M, Bermúdez-López M, Fernández E, Betriu À, Rodríguez I, Valdivielso JM.

Front Genet. 2019 Feb 26;10:118. doi: 10.3389/fgene.2019.00118. eCollection 2019.

5.

Peritoneal Dialysis Is an Independent Factor Associated to Lower Intima Media Thickness in Dialysis Patients Free From Previous Cardiovascular Disease.

Borràs M, Cambray S, Crespo-Masip M, Pérez-Fontán M, Bozic M, Bermudez-López M, Fernández E, Betriu À, Valdivielso JM.

Front Physiol. 2018 Dec 4;9:1743. doi: 10.3389/fphys.2018.01743. eCollection 2018.

6.

Versatile Bioconjugation Chemistries of ortho-Boronyl Aryl Ketones and Aldehydes.

Cambray S, Gao J.

Acc Chem Res. 2018 Sep 18;51(9):2198-2206. doi: 10.1021/acs.accounts.8b00154. Epub 2018 Aug 15.

7.

Phage Display of Dynamic Covalent Binding Motifs Enables Facile Development of Targeted Antibiotics.

McCarthy KA, Kelly MA, Li K, Cambray S, Hosseini AS, van Opijnen T, Gao J.

J Am Chem Soc. 2018 May 16;140(19):6137-6145. doi: 10.1021/jacs.8b02461. Epub 2018 May 3.

8.

The rs2108622 polymorphism is related to the early risk of ischemic stroke in non-valvular atrial fibrillation subjects under oral anticoagulation.

Colàs-Campàs L, Royo JL, Montserrat MV, Marzo C, Molina-Seguín J, Benabdelhak I, Cambray S, Purroy F.

Pharmacogenomics J. 2018 Sep;18(5):652-656. doi: 10.1038/s41397-017-0007-z. Epub 2017 Dec 22.

PMID:
29273767
9.

Metabolomic Estimation of the Diagnosis and Onset Time of Permanent and Transient Cerebral Ischemia.

Cambray S, Portero-Otin M, Jové M, Torreguitart N, Colàs-Campàs L, Sanz A, Benabdelhak I, Yemisci M, Dalkara T, Dönmez-Demir B, Egea J, Purroy F.

Mol Neurobiol. 2018 Jul;55(7):6193-6200. doi: 10.1007/s12035-017-0827-5. Epub 2017 Dec 21.

PMID:
29270918
10.

Fluorogenic diazaborine formation of semicarbazide with designed coumarin derivatives.

Cambray S, Bandyopadhyay A, Gao J.

Chem Commun (Camb). 2017 Nov 21;53(93):12532-12535. doi: 10.1039/c7cc07389e.

11.

Fast and selective labeling of N-terminal cysteines at neutral pH via thiazolidino boronate formation.

Bandyopadhyay A, Cambray S, Gao J.

Chem Sci. 2016 Jul 1;7(7):4589-4593. doi: 10.1039/C6SC00172F. Epub 2016 Apr 4.

12.

A Current Estimation of the Early Risk of Stroke after Transient Ischemic Attack: A Systematic Review and Meta-Analysis of Recent Intervention Studies.

Valls J, Peiro-Chamarro M, Cambray S, Molina-Seguin J, Benabdelhak I, Purroy F.

Cerebrovasc Dis. 2017;43(1-2):90-98. doi: 10.1159/000452978. Epub 2016 Dec 20. Review.

PMID:
27992865
13.

Fast Diazaborine Formation of Semicarbazide Enables Facile Labeling of Bacterial Pathogens.

Bandyopadhyay A, Cambray S, Gao J.

J Am Chem Soc. 2017 Jan 18;139(2):871-878. doi: 10.1021/jacs.6b11115. Epub 2017 Jan 3.

14.

Metabolomics Predicts Neuroimaging Characteristics of Transient Ischemic Attack Patients.

Purroy F, Cambray S, Mauri-Capdevila G, Jové M, Sanahuja J, Farré J, Benabdelhak I, Molina-Seguin J, Colàs-Campàs L, Begue R, Gil MI, Pamplona R, Portero-Otín M.

EBioMedicine. 2016 Dec;14:131-138. doi: 10.1016/j.ebiom.2016.11.010. Epub 2016 Nov 9.

15.

Clinical Evolution of Elderly Adults with Ischemic Stroke.

Vena AB, Cambray S, Molina-Seguin J, Colàs-Campàs L, Sanahuja J, Quílez A, González-Mingot C, Gil-Villar MP, Benabdelhak I, Mauri-Capdevila G, Purroy F.

J Am Geriatr Soc. 2016 Oct;64(10):2167-2170. doi: 10.1111/jgs.14426. Epub 2016 Aug 26. No abstract available.

PMID:
27564081
16.

The determination of copeptin levels helps management decisions among transient ischaemic attack patients.

Purroy F, Suárez-Luis I, Cambray S, Farré J, Benabdelhak I, Mauri-Capdevila G, Sanahuja J, Quílez A, Begué R, Gil MI, Molina-Seguin J, Torreguitart N.

Acta Neurol Scand. 2016 Aug;134(2):140-7. doi: 10.1111/ane.12523. Epub 2015 Oct 16.

PMID:
26471428
17.

Activin A directs striatal projection neuron differentiation of human pluripotent stem cells.

Arber C, Precious SV, Cambray S, Risner-Janiczek JR, Kelly C, Noakes Z, Fjodorova M, Heuer A, Ungless MA, Rodríguez TA, Rosser AE, Dunnett SB, Li M.

Development. 2015 Apr 1;142(7):1375-86. doi: 10.1242/dev.117093.

18.

Metabolomics predicts stroke recurrence after transient ischemic attack.

Jové M, Mauri-Capdevila G, Suárez I, Cambray S, Sanahuja J, Quílez A, Farré J, Benabdelhak I, Pamplona R, Portero-Otín M, Purroy F.

Neurology. 2015 Jan 6;84(1):36-45. doi: 10.1212/WNL.0000000000001093. Epub 2014 Dec 3.

19.

Slipping up: partial substrate degradation by ATP-dependent proteases.

Nassif ND, Cambray SE, Kraut DA.

IUBMB Life. 2014 May;66(5):309-17. doi: 10.1002/iub.1271. Epub 2014 May 14. Review.

20.

FLRT3 is a Robo1-interacting protein that determines Netrin-1 attraction in developing axons.

Leyva-Díaz E, del Toro D, Menal MJ, Cambray S, Susín R, Tessier-Lavigne M, Klein R, Egea J, López-Bendito G.

Curr Biol. 2014 Mar 3;24(5):494-508. doi: 10.1016/j.cub.2014.01.042. Epub 2014 Feb 20.

21.

N-terminal pro-brain natriuretic peptide level determined at different times identifies transient ischaemic attack patients with atrial fibrillation.

Purroy F, Suárez-Luis I, Mauri-Capdevila G, Cambray S, Farré J, Sanahuja J, Piñol-Ripoll G, Quílez A, González-Mingot C, Begué R, Gil MI, Fernández E, Benabdelhak I.

Eur J Neurol. 2014 Apr;21(4):679-83. doi: 10.1111/ene.12222. Epub 2013 Jun 25.

PMID:
23800180
22.

Activin induces cortical interneuron identity and differentiation in embryonic stem cell-derived telencephalic neural precursors.

Cambray S, Arber C, Little G, Dougalis AG, de Paola V, Ungless MA, Li M, Rodríguez TA.

Nat Commun. 2012 May 15;3:841. doi: 10.1038/ncomms1817.

23.

Protein kinase KIS localizes to RNA granules and enhances local translation.

Cambray S, Pedraza N, Rafel M, Garí E, Aldea M, Gallego C.

Mol Cell Biol. 2009 Feb;29(3):726-35. doi: 10.1128/MCB.01180-08. Epub 2008 Nov 17.

24.

A comparative evaluation of secretin bolus and secretin infusion as secretin provocation tests in the Zollinger-Ellison syndrome.

Mignon M, Rigaud D, Cambray S, Chayvialle JA, Accary JP, René E, Vatier J, Bonfils S.

Scand J Gastroenterol. 1985 Sep;20(7):791-7.

PMID:
4048832

Supplemental Content

Loading ...
Support Center